Stay updated on Adagrasib + BI 1701963 in Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.

Latest updates to the Adagrasib + BI 1701963 in Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision history now lists Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe Record History now includes a new Revision entry for v3.3.2 and removes the v3.2.0 entry, representing a small release-level update to the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe funding-related operating status notice was removed from the page, which previously informed users that information may not be up to date due to lapses in government funding and directed users to cc.nih.gov and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check58 days agoChange DetectedNew versions of the record include updates to Study Status and Recruitment Status, showing how the trial's activity and enrollment have changed over time.SummaryDifference0.1%

- Check87 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference12%

- Check94 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release tag is now in effect.SummaryDifference0.3%

Stay in the know with updates to Adagrasib + BI 1701963 in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.